Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit.No published studies have quantified the medical costs and healthcare resource utilization among patients with vitiligo in the United States compared with the general population.
Drawing from the Merative MarketScan Commercial Claims and Encounters database, researchers retrospectively reviewed the records of 49,512 patients diagnosed with vitiligo between January 1, 2008, and December 31, 2020, and those of 99,024 matched control persons who did not have vitiligo. Costs were in 2021 dollars during a 1-year post-index period. The student t test and chi square analysis were used to determineIn both cohorts, the median age of patients was 43 years, 79.2% were female, and most were from the southern region of the United States.
All-cause total healthcare costs for patients with vitiligo were significantly higher than those of matched control persons , as were pharmacy costs , ≥1 inpatient visits , and ≥1 outpatient visits (99.8% vs 88.3%;"These findings reveal an unmet need for cost-effective treatments and highlight the importance of fully identifying the drivers of economic burden for patients with vitiligo," the authors concluded.
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see ourComments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses.